Abstract

This chapter presents my clinical approach to neuropsychiatric patients including application of QEEG/LORETA for the confirmation of diagnosis and use of LORETA Z-score neurofeedback (NFB) in therapy. Introduction of QEEG/LORETA brain imaging has improved our diagnostic ability in neuropsychiatric practice by identification of dysregulated cortical areas implicated in patients’ symptoms. Additional use of LORETA Z-score NFB enables us to directly target these areas of dysregulation in order to improve symptoms associated with them. Based on approximately 260 patients treated in our clinic with Z-score LORETA NFB and suffering from different neuropsychiatric conditions, detailed analyses of representative cases are presented. Specific areas of cortical dysregulation identified by QEEG/LORETA are described, and results of computerized cognitive testing are presented. Follow-up findings of QEEG/LORETA electrical imaging after NFB and computerized cognitive testing indicating NFB mediated cognitive enhancement will be shown. Several major groups will be discussed including patients diagnosed with TBI, cerebrovascular disease (CVA), chronic pain/headaches, seizures/epilepsy, a static (non-progressing) cognitive dysfunction, progressing cognitive dysfunction including Alzheimer’s disease (AD), anxiety/depression, ADD/ADHD, as well as autistic spectrum disorder (ASD).